Vivus (VVUS)
Create an Alert
14.30
+0.54 +3.92%
NASDAQ
Jun 19, 3:41PM
BATS Real time
Currency in USD
Vivus Return on Equity:
-66.91% for March 31, 2013Vivus Historical Return on Equity Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -66.91% |
| Dec. 31, 2012 | -55.03% |
| Sept. 30, 2012 | -39.50% |
| June 30, 2012 | -30.35% |
| March 31, 2012 | -32.20% |
| Dec. 31, 2011 | -34.88% |
| Sept. 30, 2011 | -31.42% |
| June 30, 2011 | -38.57% |
| March 31, 2011 | -40.00% |
| Dec. 31, 2010 | -42.64% |
| Sept. 30, 2010 | -43.23% |
| June 30, 2010 | -46.18% |
| March 31, 2010 | -41.60% |
| Dec. 31, 2009 | -35.83% |
| Sept. 30, 2009 | -33.86% |
| June 30, 2009 | -22.95% |
| March 31, 2009 | -9.37% |
| Dec. 31, 2008 | -11.05% |
| Sept. 30, 2008 | 9.73% |
| June 30, 2008 | 14.86% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Return on Equity (ROE)
Return on equity (ROE) measures the rate of return on the money invested by common stock owners and retained by the company thanks to previous profitable years. It demonstrates a company's ability to generate profits from shareholders' equity (also known as net assets or assets minus liabilities).
ROE shows how well a company uses investment funds to generate growth. Return on equity is useful for comparing the profitability of companies within a sector or industry.
Investors generally are interested in company's that have high, increasing returns on equity.
Learn More
VVUS Return on Equity Benchmarks
| Companies | |
|---|---|
| Arena Pharmaceuticals | -86.62% |
| Orexigen Therapeutics | -114.9% |
| XOMA | -1387% |
VVUS Return on Equity Rankings
| Overall |
61st percentile 6438 of 16782 |
| Sector |
63rd percentile 509 of 1410 in Healthcare |
| Industry |
72nd percentile 127 of 454 in Biotechnology |
VVUS Return on Equity Range, Past 5 Years
| Minimum | -66.91% | Mar 2013 |
| Maximum | 14.86% | Jun 2008 |
| Average | -31.55% |
